Leslie J. Williams insider trades
Open-market stock purchases and sales by Leslie J. Williams, Director at Ocular Therapeutix, Inc, from SEC Form 4 filings since Jun 14, 2019.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +87%.